The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
Open accessThe DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are usually associated with loss of dopaminergic neurons. Loss of substantia nigra neurons and presence of Lewy body inclusions in some of the remaining neurons are the hallmark pathology seen in the final stages of the disease. Attempts to correlate Lewy body pathology to either cell death or severity of clinical symptoms, however, have not been successful. While the pathophysiology of the neurodegenerative process can hardly be explained by Lewy bodies, the clinical symptoms do indicate a degenerative process located at the presynapse resulting in a neurotransmitter deficiency. Recently it was shown that 90% or even more of alpha-synuclein aggregates in DLB cases were located at the presynapses in the form of very small deposits. In parallel, dendritic spines are retracted, whereas the presynapses are relatively preserved, suggesting a neurotransmitter deprivation. The same alpha-synuclein pathology can be demonstrated for PD. These findings give rise to the notion that not cell death but rather alpha-synuclein aggregate-related synaptic dysfunction causes the neurodegeneration. This opens new perspectives for understanding PD and DLB. If presynaptic alpha-synuclein aggregation, not neuronal loss, is the key issue of the neurodegenerative process, then PD and DLB may eventually be treatable in the future. The disease may progress via trans-synaptical spread, suggesting that stem cell transplants are of limited use. Future therapies may focus on the regeneration of synapses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PD is associated with four cardinal motor symptoms, including tremors, rigidity, bradykinesia, and postural instability, alongside the characteristic shuffling and stooped posture of the “Parkinsonian gait” [46].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“It could be demonstrated that the presence of symptoms may be related to the involvement of defined regions as measured by the occurrence of Lewy bodies [47–49], supporting the observations that the a-synuclein aggregation pathology spreads through the brain involving anatomical structures sequentially [13].”
BackgroundAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“The discovery of mutations in the a-synuclein gene [77, 114, 156] and overexpression of a-synuclein [123] as being associated with Parkinson’s disease or dementia with Lewy bodies (DLB) strengthens the association between protein”
BackgroundParkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · cited 2×
“Tremor at rest, rigidity, akinesia/bradykinesia and postural instability are the four cardinal features in Parkinson’s disease [60].”
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · cited 1×
“association between the frequency and extension of tangles and Ab-plaques and the occurrence of the disease [55, 104], Terry et al.”
BackgroundChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“It was assumed that the cognitive impairment in AD is related to a synaptic failure [121, 124, 130].”
Background
Cited by
Items 501–600 of 664
Iron Metabolism in Parkinson’s Disease
Gao, G., You, L., & Chang, Y. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00255 · Cited by 2
Robles, D. J. S. J., Rodriguez, R. C. N. T., Romana, N. B. S., Rosales, J. M. B., Rosales, M. C. E., Salazar, G. B., & Rosales, R. L. (2017) · Journal of Medicine University of Santo Tomas · doi:10.35460/2546-1621.2017-0057 · Cited by 2
Parkinson’s Disease and Parkinson’s Disease Dementia
DeRight, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-85372-3_33 · Cited by 2
Ghazanfari, N., van Waarde, A., Doorduin, J., Sijbesma, J. W. A., Kominia, M., Koelewijn, M., Attia, K. A., García, D. V., Willemsen, A. T. M., Heeres, A., et al. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00121 · Cited by 2
Graf, S., Ludwig, N., Flotho, M., Engel, A., Diks, I. F., Zimmer, P., Wemheuer, W. M., Wrede, A., Mîrzac, D., González‐Escamilla, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.15.643484 · Cited by 2
Self-citationAstrocytes and the Synucleinopathies
Koob, A. O., & Sacchetti, P. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_8 · Cited by 1
Drug Delivery Strategies in Parkinson’s Disease
Singh, G., Sikder, A., Singh, S. B., Srivastava, S., & Khatri, D. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-6807-7_13 · Cited by 1
Esophageal Achalasia in Parkinson’s Disease: Diagnosis and Management of a Rare Case
Ioannou, A., & Torresan, F. (2024) · Translational Medicine UniSa · doi:10.37825/2239-9747.1052 · Cited by 1
Epigenetic and Metabolic Landscape of Dementia with Lewy Bodies
Vishweswaraiah, S., Yılmaz, A., Gordevičius, J., Milčiūtė, M., Krinickis, K., Kerševičiūtė, I., McGuinness, B., Passmore, P., Kehoe, P. G., Green, B. D., et al. (2024) · Movement Disorders · doi:10.1002/mds.30095 · Cited by 1
Baumann, C. R., Brockmann, K., & Berg, D. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108989855.019 · Cited by 1
Elucidating the role of APOE ε4 gene variants in the clinical manifestation of Parkinson's disease
Soraya, G. V., Fitrah, Y. A., Bintang, A. K., Akbar, M., Jannah, A. R., Ulhaq, Z. S., Tammasse, J., Kaelan, C., Massi, M. N., Obinata, A., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1632480 · Cited by 1
Dementia and Diet: How Nutrients Can Influence Cognitive Decline
Sonkar, P., Saif, M., & Sonkar, A. (2026) · Springer eBooks · doi:10.1007/978-981-95-4169-0_10 · Cited by 1
Compensatory hallucinogenesis across three neuropsychiatric disorders: a Bayesian account
Vin, R., Galbraith, J., Seabury, R. D., Yi, H. Y., Hernández-Busot, G., Oland, L., Epié, B., Trainer, A. E., Fredericks, C. A., & Powers, A. R. (2026) · Brain Communications · doi:10.1093/braincomms/fcag001 · Cited by 1
Nuclear receptors in age-related diseases: From mechanisms to drug discovery
Zhang, L., Li, X., Ren, C., Hao, Y., Deng, Y., Pan, H., Kim, Y.-B., Fan, S., Huang, C., Ge, G., et al. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103125 · Cited by 1
Seeing Invisible Oligomers: Rethinking α‐Synuclein Pathology Through Proximity Ligation Assay
Sekiya, H., Jensen, N. M., Dickson, D. W., & Jensen, P. N. (2026) · Movement Disorders · doi:10.1002/mds.70335 · Cited by 1
“41,42 Although the aggregates detected by these PK-based approaches may represent species with relatively higher β -sheet content, such parallels highlight the value of integrating orthogonal methodologies to re fi ne molecular interpretation.”
Jeon, M., Jeong, J., Choi, M., Son, S., Yang, W., Cheon, M., & Kim, D.-G. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.05.025 · Cited by 1
Gong, X., Huang, J., Fu, C., Guo, S., Tan, Y., Lu, R., Liu, B., Zhao, L., Wang, S., Tong, H. H. Y., et al. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c00241 · Cited by 1
Molecular Mechanisms and Potential Biomarkers of Neuropsychiatric Disorders in Parkinson’s Disease
Owecki, W., Futyma, A., Kokorniak, O., Szczech, A., Słowikowski, B. K., Poszwa, J., Szymanowicz, O., Goutor, U., Jagodziński, P. P., Kozubski, W. P., et al. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin50055 · Cited by 1
Serravalle, S., Lolicato, F., Tempra, C., Pannuzzo, M., Sciacca, M. F. M., Milardi, D., & Rosa, C. L. (2026) · ChemBioChem · doi:10.1002/cbic.70398 · Cited by 1
Loewenstein, D., van Grinsven, M., de Pont, C., Arens, A. I. J., DAUTZENBERG, P. L. J., van Strien, A. M., Sabri, O., Hesse, S., Rullmann, M., Henssen, D. J. H. A., et al. (2026) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-026-07925-z · Cited by 1
Argibay, U., Sancho‐Alonso, M., Yanes-Castilla, C., Jericó-Escolar, J., Paz, V., Ruiz‐Bronchal, E., Miquel-Rio, L., & Bortolozzi, A. A. (2026) · Biomedicines · doi:10.3390/biomedicines14061394 · Cited by 1
α‐Synuclein aggregation landscape from phase separation to neurotoxic intermediates
Ariño, S., Fusco, G., & Simone, A. D. (2026) · FEBS Letters · doi:10.1002/1873-3468.70393 · Cited by 1
Arbab, S., Ullah, H., Han, Y., Zhou, J., & Li, K. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103263 · Cited by 1
Human microglia clear intraneuronal α-synuclein aggregates by GPNMB-mediated trogocytosis
Chueh, H.-J., Katsikoudi, A., Aragón-González, A., Lam, C. L., Tamon, L., Jainarayanan, A., Agarwal, D., Cowley, S. A., Sims, D., & Tofaris, G. K. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adz9258 · Cited by 1
“Initial α -synuclein aggregates in animal models (38) and human PD brain (39) localise predominantly in presynaptic terminals, raising the possibility that these are the earliest sites of microglial trogocytosis.”
Wemheuer, W. M., Martens, D., Nessis, L., Kulas, P., Pillong, L., Rosar, F., Redl, K., Lechler, A., Wrede, A., Fassbender, K. C., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000218704 · Cited by 1
Self-citationNeuronal Death Mechanisms in Development and Disease
Cusack, C. L., Annis, R. P., Kole, A. J., & Deshmukh, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9302-0_8 · Cited by 1
“Alphasynuclein can be secreted by neurons, partake in cell-to-cell transmission, induce neurotoxicity, make neurons more sensitive to apoptosis, and trigger infl ammatory glial responses [ 104 , 107 , 108 ].”
BackgroundSchulz‐Schaeffer, W. (2011) · Future Neurology · doi:10.2217/fnl.11.57 · Cited by 1
Self-citationTreglia, G., Ceriani, L., & Giovanella, L. (2014) · Current Radiopharmaceuticals · doi:10.2174/1874471007666140314094323 · Cited by 1
“In fact, Lewy bodies, intra-neuronal precipitates containing alphasynuclein protein aggregates, are pathologically observed in the nervous system of these neurodegenerative diseases [5, 6].”
BackgroundAlzheimer's disease - neurological or psychiatric disorder?
Poalelungi, A., & Popescu, B. O. (2013) · Romanian Journal of Neurology · doi:10.37897/rjn.2013.1.1 · Cited by 1
Mutual Neurotoxic Mechanisms Controlling Manganism and Parkisonism
Roth, J. A. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622383-00221 · Cited by 1
History and Latest Concepts of Lewy Body Disease and Dementia with Lewy Bodies
Kosaka, K. (2016) · Springer eBooks · doi:10.1007/978-4-431-55948-1_1 · Cited by 2
Obstructive Sleep Apnea in Parkinson’s Disease—a Mini-Review
Neikrug, A. B. (2018) · Current Sleep Medicine Reports · doi:10.1007/s40675-018-0111-x · Cited by 1
Cell and Tissue Destruction in Selected Disorders
Arnhold, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816388-7.00009-7 · Cited by 1
Shahnawaz, M., & Soto, C. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00020-3 · Cited by 1
DeRight, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-85372-3_15 · Cited by 1
Sistema nervioso central y regulación de la respuesta inmune
Ulises Vergara, C. (2011) · Avances en Ciencias Veterinarias · doi:10.5354/0716-260x.2011.17531 · Cited by 2
Glebov, O. O., Williamson, D. J., Owen, D. M., Hortobágyi, T., Troakes, C., & Aarsland, D. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12852 · Cited by 1
Hsc70 rescues the synaptic vesicle trafficking defects caused by α-synuclein dimers
Brady, E. B., McQuillan, M., Medeiros, A. T., Bubacco, L., Sousa, R., Lafer, E. M., & Morgan, J. R. (2023) · PubMed Central · doi:10.17912/micropub.biology.000737 · Cited by 1
Neuropathology of Neurological Disorders
Rather, M. A., Khan, A., Javed, H., Jahan, S., Tabassum, R., & Begum, R. (2024) · Springer eBooks · doi:10.1007/978-981-99-9404-5_1 · Cited by 2
Rivera, C. V. C., Wallace, J. N., Fisher, G. E., & Morgan, J. R. (2024) · PubMed Central · doi:10.17912/micropub.biology.001206 · Cited by 1
Kumar, D. S., Ravi, R., Mahmood, A. A. R., Amirkhanyan, N., & Polevoy, G. G. (2025) · Global Journal of Medical Pharmaceutical and Biomedical Update · doi:10.25259/gjmpbu_42_2024 · Cited by 2
Aarsland, D., Cummings, J. L., Weintraub, D., & Chaudhuri, К. R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.002 · Cited by 1
Neurogenesis in the adult brain, gene networks, and Alzheimer's Disease
Horgusluoglu, E. (2017) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1972 · Cited by 1
Mechanisms of Aggresome Biogenesis Ubiquitination, Transport, & MaintenancePreprint
Keefe, A. (2018) · Preprints.org · doi:10.20944/preprints201812.0332.v1 · Cited by 1
Ibrahim, T. (2015) · TSpace (University of Toronto) · Cited by 1
Longhena, F., Zheng, Z., Faustini, G., Węgrzynowicz, M., Carlson, E., Casadei, N., Riess, O., Bellucci, A., & Spillantini, M. G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.13.647581 · Cited by 1
Evaluation of submandibular gland biopsies with RT-QuIC in Parkinson’s disease under investigationPreprint
Wemheuer, W. M., Martens, D., Spiegel, J., Nessis, L., Kulas, P., Pillong, L., Rosar, F., Redl, K., Lechler, A., Wrede, A., et al. (2025) · medRxiv · doi:10.1101/2025.10.22.25337489 · Cited by 1
Self-citationDopaminergic Dysfunction in Experimental Hepatic Encephalopathy
Suárez, I., Bodega, G., & Fernández, B. (2012) · InTech eBooks · doi:10.5772/29078
Targeting α-Synuclein-Related Synaptic Pathology: Novel Clues for Parkinson’s Disease Therapy
Bellucci, A., & Spano, P. (2011) · InTech eBooks · doi:10.5772/17631
“neurodegeneration (Schulz-Schaeffer, 2010;Kramer et al., 2008).”
BackgroundInfluentialBlanc, A. (2013) · Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine)
Sustrato Patológico de las Sinucleinopatías. Introducción
Román, I. F. (2011) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2011.10.001
Methods for treating neurological conditions (WO2011159945)
Meissner, W. G. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.699524
Gomperts, S. N., Marquié, M., Locascio, J. J., Rentz, D. M., Becker, J. A., Hedden, T., Johnson, K. A., & Growdon, J. H. (2014) · Neurology · doi:10.1212/wnl.82.10_supplement.p2.009
Regulation of neuronal death by the autophagy lysosomal pathway: Implications for Parkinson disease
Pivtoraiko, V. N. (2011) · ProQuest Demo Repository
Aarsland, D., Cummings, J. L., Weintraub, D. A., & Chaudhuri, К. R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.006
Wietelmann, D., & Hüll, M. (2015) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-015-1135-0
Castro, E., Sportiello, M. T., & Cammisuli, D. M. (2014) · Journal of Aging and Gerontology · doi:10.12974/2309-6128.2014.02.02.5
Unruhige Nächte und verschlafene Tage: Psychiatrische Kasuistik
Peters, O., Koglin, A., Rudolph, A., & Schulz‐Schaeffer, W. (2013) · NeuroTransmitter · doi:10.1007/s15016-013-0062-x
“Die präsynaptische α-Synukleinaggregation geht mit einer postsynaptischen Degeneration der Dendritenköpfchen einher, womit die Symptome der Neurodegeneration durch eine Unterbrechung der Signalübertragung erklärt werden können [9].”
BackgroundSelf-citationExenatide as a novel treatment for Parkinson's Disease
Avilés-Olmos, I. (2013) · UCL Discovery (University College London)
Alafuzoff, I. I., Pikkarainen, M., & Parkkinen, L. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660.009 · Cited by 2
Mollenhauer, B., & Zetterberg, H. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.010
Parkinson’s disease: pathology, anatomy, and behavior
Burdick, D. J., & Leverenz, J. B. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.003
The molecular intersection between axon-specific pruning and neuronal apoptosis
Cusack, C. L. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/rrx2-2p18
The role of the nucleolus in neurodegeneration.
Hallgren, J. (2016) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2547
Pathogenic mechanisms in multiple system atrophy: a study of oligodendroglial pathology
Asi, Y. T. (2014) · UCL Discovery (University College London)
Aggregation of alpha-synuclein using single-molecule spectroscopy
Iljina, M. (2017) · Apollo (University of Cambridge) · doi:10.17863/cam.8525
Biomarkers in dementia with Lewy bodies
Donaghy, P. C. (2016)
Methionine Sulfoxide Reductase and Ubiquitin-dependent Degradation of Alpha-synuclein
Deng, Y. (2017) · KU ScholarWorks (The University of Kansas)
Cycads, Flying Foxes, and Brain Disease in Humans
Disney, L. (2018) · UKnowledge (University of Kentucky)
Alireza, T. (2017) · Spiral (Imperial College London) · doi:10.25560/60641
Bartels, M. (2017) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.24950
Murray, L. (2018) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2018-13371
Learning Phenotypic Associations for Parkinson’s Disease with Longitudinal Clinical RecordsPreprint
Pan, W., Su, C., Chen, K., Henchcliffe, C., & Wang, F. (2020) · medRxiv · doi:10.1101/2020.03.15.20036657
O metabolismo de apolipoproteínas e lipoproteínas na doença de Parkinson
Milchareck, A., Blembeel, A. S., Dani, C., & Funchal, C. (2020) · Revista Brasileira Multidisciplinar · doi:10.25061/2527-2675/rebram/2020.v23i3.714 · Cited by 1
The role of biometals in the neuropathology of Parkinson’s disease
Genoud, S. (2020) · The Sydney eScholarship Repository (The University of Sydney)
Ferrara, N., Komici, K., & Corbi, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_30-1
Libertini, G., Corbi, G., Conti, V., Shubernetskaya, O. S., & Ferrara, N. (2021) · Advances in studies of aging and health · doi:10.1007/978-3-030-73774-0_6
PCA-LBD in Gaucher disease type 1: a case description
Curti, D. G., Caso, F., Malvaso, A., Cardamone, R., Martinelli, V., Magnani, G., & Filippi, M. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05648-7
Ferrara, N., Komici, K., & Corbi, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_30
The Aging Brain: From Physiology to Neurodegeneration
Rajput, R., Kaur, R., Chadha, R., Mani, S., Rachana, R., Kaur, H., & Singh, M. (2022) · IGI Global eBooks · doi:10.4018/978-1-6684-5295-0.ch008
Sivalingam, D., Amirshahi, S., Thyagarajan, K., Tofig, B., & Stein, M. (2011) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a001968.01
Mechanisms of Aggresome Biogenesis: Ubiquitination, Transport, & MaintenancePreprint
Keefe, A. (2019) · Preprints.org · doi:10.20944/preprints201812.0332.v2
An Understanding of Different Mechanisms Leading to Neurodegenerative Diseases
Sami, D. G., & Salama, M. (2023) · Springer eBooks · doi:10.1007/978-981-19-3949-5_10-1 · Cited by 1
Neurotoxicity in the treatment of Parkinson's disease
Siritsa, N. Y. (2023) · Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice · doi:10.37489/2588-0519-2023-2-85-90
Birla, D., Mahendra Kumar, R., Potale, Y., Kumar, S., Singh, G., & Kumar, A. (2024) · BIO Web of Conferences · doi:10.1051/bioconf/20248601028
“The precise mechanisms that cause this misfolding are currently the subject of rigorous research [3].”
BackgroundManoj, M., Sowmyanarayan, S., Kowshik, A. V., & Chatterjee, J. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02199-2
“…years, they are considerably known to be cytotoxic, due to their rise directly resulting in neural cell loss and tissue degradation in the brain (Schulz-Schaeffer 2010). α-Synuclein is the distinctive soluble protein that tends to aggregate and interact with neural DNA, causing its marked…”
Neurotrophins and Phytochemicals: Potential Partners to Combat Neurodegenerative Diseases
Jayaraman, M., Dutta, A., Mahanta, S., Sivakumar, D., & Raghavendran, H. R. B. (2024) · Springer eBooks · doi:10.1007/978-981-99-7269-2_13
Investigations of Synaptic Alterations in Models of Parkinson’s Disease
Al‐Azzani, M. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10585
Schueller, E., Grgurina, I., Cosquer, B., Panzer, É., Penaud, N., de Vasconcelos, A. P., Stéphan, A., Mérienne, K., Cassel, J., Mathis, C., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106676
“Animal care and experimental protocols were in accordance with the institutional guidelines and directive 2010/63/EU on the protection of animals used for scientific purposes (European parliament and council, September 22, 2010).”
An Understanding of Different Mechanisms Leading to Neurodegenerative Diseases
Sami, D. G., & Salama, M. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_10
Frantzeskos, S. A., Biggs, M. A., & Banerjee, I. A. (2024) · Biomimetics · doi:10.3390/biomimetics9110705
Farhan, S. M. K., Fiorini, M. R., Li, J., Fon, E. A., & Thomas, R. A. (2024) · Research Square · doi:10.21203/rs.3.rs-5471740/v1
Son, Y.-S., Ko, E., & Jung, S. (2024) · Journal of Applied Biological Chemistry · doi:10.3839/jabc.2024.058
Synaptotoxic forms of amyloid-β and α-synuclein act through a common pathwayPreprint
Ribé, E. M., Ghosh, A., Pasławski, W., Savory, K., Ballard, C. G., Morin, P., Cash, D., Hirth, F., Williams, G. H., Svenningsson, P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.13.638131
Libertini, G., Corbi, G., Shubernetskaya, O. S., Komici, K., & Ferrara, N. (2024) · Advances in studies of aging and health · doi:10.1007/978-3-031-84877-3_8
Faustini, G., Mazzocco, M. T., Comelli, A., Brugnoli, A., Benfante, V., Brembati, V., Longhena, F., Gennari, M. M., Coliva, A., Magnino, S., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6502918/v1
Assessment of Autonomic Function in Iraqi Patients with Parkinson’s Disease
Al-Janabi, A. A., & Ameer, A. H. (2025) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v8i2.1875
HOPES AND HURDLES OF DENDRIMERS FOR THE TREATMENT OF PARKINSON’S DISEASE
AGGARWAL, K., Verma, S., RATHORE, A. S., & Parashar, T. (2025) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2025v18i6.54401
Fluid and Imaging Markers of Synaptic Injury
Tarawneh, R. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_4
Metadata
- Authors
- Schulz-Schaeffer, W. J.
- Venue
- Acta Neuropathologica
- Published
- 2010-06-20
- Volume
- 120
- Issue
- 2
- Pages
- 131-143
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC2892607
- OpenAlex
- W2033827101
- Cited by
- 627
- References
- 165
- Citations by year
- 2026: 38 · 2025: 51 · 2024: 45 · 2023: 24 · 2022: 43 · 2021: 48 · 2020: 48 · 2019: 41 · 2018: 40 · 2017: 35 · 2016: 36 · 2015: 29 · 2014: 41 · 2013: 36 · 2012: 35
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- GRO (submittedVersion, cc-by)
- Funders
- Volkswagen Foundation (ZN 2168)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- alpha-synuclein aggregation, Lewy bodies, dementia with Lewy bodies, Parkinson's disease, Parkinson's disease dementia, presynaptic dysfunction, synaptic pathology, neurotransmitter deficiency, neurodegeneration, trans-synaptic spread, stem cell transplantation, synapse regeneration
- MeSH terms
- Animals, Brain, Parkinson Disease, Synapses, Lewy Body Disease, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.